Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon R Mucha

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cleveland Clinic Journal of Medicine|August 8, 2020
Convalescent plasma for COVID-19: Promising, not provenSimon R Mucha, NurJehan Quraishy
Current Oncology (Toronto, Ont.)|May 26, 2023
Management and Prevention of Cellular-Therapy-Related Toxicity: Early and Late ComplicationsSimon R Mucha, Prabalini Rajendram
Cleveland Clinic Journal of Medicine|November 1, 2023
Cirrhotic coagulopathy: A rebalanced hemostasisAchintya D Singh, Simon R Mucha, Christina C Lindenmeyer
Cleveland Clinic Journal of Medicine|December 16, 2020
Update to coagulopathy in COVID-19: Manifestations and managementSimon R Mucha, Siddharth Dugar, Keith McCrae, et al.
Cleveland Clinic Journal of Medicine|November 24, 2020
In Reply: COVID-19 coagulopathySimon R Mucha, Siddharth Dugar, Keith McCrae, et al.
Cleveland Clinic Journal of Medicine|May 16, 2020
Coagulopathy in COVID-19: Manifestations and managementSimon R Mucha, Siddharth Dugar, Keith McCrae, et al.
Cancer Research|August 3, 2005
Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrestChristian Kuntzen, Nilüfer Sonuc, Enrico N De Toni, et al.
Journal of Hepatology|January 17, 2007
P60-c-src suppresses apoptosis through inhibition of caspase 8 activation in hepatoma cells, but not in primary hepatocytesEnrico N De Toni, Christian Kuntzen, Alexander L Gerbes, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cleveland Clinic Journal of Medicine|August 8, 2020
Convalescent plasma for COVID-19: Promising, not provenSimon R Mucha, NurJehan Quraishy
Current Oncology (Toronto, Ont.)|May 26, 2023
Management and Prevention of Cellular-Therapy-Related Toxicity: Early and Late ComplicationsSimon R Mucha, Prabalini Rajendram
Cleveland Clinic Journal of Medicine|November 1, 2023
Cirrhotic coagulopathy: A rebalanced hemostasisAchintya D Singh, Simon R Mucha, Christina C Lindenmeyer
Cleveland Clinic Journal of Medicine|December 16, 2020
Update to coagulopathy in COVID-19: Manifestations and managementSimon R Mucha, Siddharth Dugar, Keith McCrae, et al.
Cleveland Clinic Journal of Medicine|November 24, 2020
In Reply: COVID-19 coagulopathySimon R Mucha, Siddharth Dugar, Keith McCrae, et al.
Cleveland Clinic Journal of Medicine|May 16, 2020
Coagulopathy in COVID-19: Manifestations and managementSimon R Mucha, Siddharth Dugar, Keith McCrae, et al.
Cancer Research|August 3, 2005
Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrestChristian Kuntzen, Nilüfer Sonuc, Enrico N De Toni, et al.
Journal of Hepatology|January 17, 2007
P60-c-src suppresses apoptosis through inhibition of caspase 8 activation in hepatoma cells, but not in primary hepatocytesEnrico N De Toni, Christian Kuntzen, Alexander L Gerbes, et al.
Pageof 1